Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AORT
AORT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AORT News
Analysis of Stocks Under $50
Apr 13 2026
Yahoo Finance
Artivion Shares Surge 5.3% on FDA Approval News
Apr 08 2026
NASDAQ.COM
Artivion Receives FDA Approval for NEXUS Aortic Arch System
Apr 07 2026
NASDAQ.COM
Artivion Receives FDA Approval for NEXUS System
Apr 07 2026
NASDAQ.COM
Endospan's NEXUS Stent Graft System Approved by FDA for Aortic Arch Disease
Apr 07 2026
PRnewswire
Endospan's NEXUS Stent Graft System Receives FDA Approval
Apr 07 2026
Newsfilter
Investment Opportunities in Healthcare Sector Analysis
Apr 04 2026
Yahoo Finance
Artivion to Participate in Oppenheimer Healthcare Conference
Mar 03 2026
PRnewswire
Artivion, Inc. Reports Strong Q4 2025 Earnings Growth
Feb 13 2026
seekingalpha
Artivion (AORT) Q4 2025 Earnings Call Transcript
Feb 13 2026
NASDAQ.COM
Artivion Reports Strong 2025 Earnings, Outlook for Growth in 2026
Feb 13 2026
Yahoo Finance
HOLX's Innovative AI Mammography Identifies Overlooked Breast Cancer Cases
Dec 17 2025
NASDAQ.COM
Artivion Insider Offloads Shares Valued at $576,502, Per Recent SEC Disclosure
Nov 18 2025
Yahoo Finance
Artivion Insider Offloads Shares Valued at $264,188, Based on Recent SEC Disclosure
Nov 14 2025
Yahoo Finance
Artivion (AORT): Is the Healthcare Leader Appropriately Priced Following Recent Gains?
Nov 09 2025
Yahoo Finance
Canaccord Genuity Keeps Buy Rating on Artivion and Increases Price Target to $51
Nov 07 2025
Benzinga
Show More News
